import { EducationalContent } from '../../types';

export const stressTest: EducationalContent = {
  id: 'stresstest',
  type: 'concept',
  name: 'Cardiac Stress Test',
  nameEs: 'Prueba de Esfuerzo Cardiaco',
  levels: {
    1: {
      level: 1,
      summary: 'A cardiac stress test checks how well the heart works during physical activity by making it beat faster and harder.',
      explanation: 'A cardiac stress test is a medical exam that shows how the heart performs when it has to work harder than usual. During normal rest, the heart pumps blood at a steady, relaxed pace. But during exercise or physical effort, the heart must beat faster and pump more blood to supply oxygen to the muscles. A stress test uses this principle to look for problems that might only appear when the heart is under increased demand.\n\nDuring the most common type of stress test, a person walks on a treadmill or rides a stationary bicycle while connected to an electrocardiogram (ECG) machine. The ECG records the electrical activity of the heart through small sticky patches placed on the chest. As the exercise intensity gradually increases, doctors watch the heart rhythm, blood pressure, and any symptoms the person may experience such as chest pain, shortness of breath, or dizziness.\n\nFor people who cannot exercise due to physical limitations such as arthritis, lung disease, or other conditions, doctors can use medications instead. These pharmacologic stress tests use drugs like adenosine, dipyridamole, or dobutamine that mimic the effects of exercise on the heart by either increasing the heart rate or dilating the blood vessels.\n\nStress tests are commonly ordered when a doctor suspects coronary artery disease, which is a narrowing of the blood vessels that supply the heart. They may also be used to evaluate how well a heart treatment is working, to determine safe exercise levels after a heart attack, or to check on heart valve problems. The test typically takes about 30 to 60 minutes including preparation time, with the actual exercise portion lasting around 7 to 12 minutes.',
      keyTerms: [
        { term: 'Stress test', definition: 'A medical exam that evaluates heart function during increased physical demand, typically using exercise or medication' },
        { term: 'Treadmill', definition: 'A walking or running machine commonly used during exercise stress tests to gradually increase physical effort' },
        { term: 'ECG (Electrocardiogram)', definition: 'A recording of the electrical signals in the heart, used to monitor heart rhythm during the stress test' },
        { term: 'Coronary artery disease', definition: 'A condition where the blood vessels supplying the heart become narrowed or blocked by plaque buildup' },
        { term: 'Pharmacologic stress test', definition: 'A type of stress test that uses medication instead of exercise to increase the heart workload' }
      ],
      clinicalNotes: 'Patients should be instructed to wear comfortable clothing and walking shoes. They should avoid eating, smoking, and caffeine for at least 3 hours before the test. Certain heart medications, particularly beta-blockers, may need to be held before the test as they can blunt the heart rate response and reduce the diagnostic accuracy.'
    },
    2: {
      level: 2,
      summary: 'Cardiac stress testing evaluates myocardial perfusion and function under increased demand using exercise or pharmacologic protocols, with ECG monitoring and optional imaging modalities.',
      explanation: 'Cardiac stress testing is a cornerstone diagnostic tool in cardiology that evaluates the heart under conditions of increased oxygen demand. The fundamental principle relies on the fact that hemodynamically significant coronary artery stenoses may not produce symptoms or ECG changes at rest but become apparent when myocardial oxygen consumption rises during exercise or pharmacologic stimulation.\n\nThe standard exercise stress test follows the Bruce Protocol, the most widely used treadmill protocol. It consists of successive 3-minute stages with increasing speed and incline. Stage 1 begins at 1.7 mph on a 10% grade, and each subsequent stage increases both speed and incline. The test continues until the patient reaches the target heart rate (85% of age-predicted maximum, calculated as 220 minus age), develops significant symptoms, or demonstrates concerning ECG changes. Alternative protocols include the Modified Bruce (which adds two lower-intensity warm-up stages), the Naughton protocol (used for deconditioned patients), and bicycle ergometry.\n\nKey monitoring parameters include continuous 12-lead ECG, blood pressure measurement at each stage, symptom assessment, and functional capacity measured in metabolic equivalents (METs). Significant findings include ST-segment depression of 1 mm or more (horizontal or downsloping) measured 60-80 milliseconds after the J-point, which suggests myocardial ischemia. ST-segment elevation in leads without Q waves may indicate transmural ischemia or vasospasm.\n\nPharmacologic stress agents fall into two categories: vasodilators (adenosine, dipyridamole, regadenoson) and inotropes/chronotropes (dobutamine). Vasodilators work by dilating normal coronary arteries while diseased segments cannot dilate proportionally, creating a differential flow pattern (coronary steal phenomenon). Dobutamine directly increases heart rate and contractility, simulating exercise.\n\nStress imaging adds either nuclear perfusion imaging (using technetium-99m or thallium-201 tracers) or echocardiography to improve sensitivity and specificity. Nuclear stress tests evaluate myocardial blood flow distribution, while stress echocardiography assesses regional wall motion abnormalities that develop with ischemia.',
      keyTerms: [
        { term: 'Bruce Protocol', definition: 'The standard treadmill exercise protocol using progressive 3-minute stages of increasing speed and incline to achieve target heart rate' },
        { term: 'ST-segment depression', definition: 'A downward shift in the ST segment of the ECG tracing that indicates inadequate blood flow to the heart muscle during stress' },
        { term: 'Metabolic equivalents (METs)', definition: 'A measure of exercise capacity where 1 MET equals the oxygen consumption at rest (3.5 mL O2/kg/min); higher values indicate better fitness' },
        { term: 'Target heart rate', definition: 'The goal heart rate during exercise stress testing, typically 85% of the age-predicted maximum heart rate (220 minus age)' },
        { term: 'Coronary steal', definition: 'A phenomenon during vasodilator stress where blood is redirected away from diseased coronary territories toward healthy vessels that can dilate normally' },
        { term: 'Nuclear perfusion imaging', definition: 'An imaging technique using radioactive tracers to visualize blood flow distribution in the heart muscle during stress and rest' }
      ],
      clinicalNotes: 'Exercise stress testing without imaging has a sensitivity of approximately 68% and specificity of 77% for detecting significant coronary artery disease. Adding imaging (nuclear or echo) improves sensitivity to 85-90% and specificity to 80-90%. Always obtain a resting 12-lead ECG before starting the protocol. Absolute contraindications include acute MI within 2 days, unstable angina not stabilized with medications, symptomatic severe aortic stenosis, uncontrolled arrhythmias, and acute aortic dissection.'
    },
    3: {
      level: 3,
      summary: 'Stress testing encompasses exercise and pharmacologic protocols with ECG, nuclear imaging, or echocardiographic modalities, each with specific indications, diagnostic accuracy profiles, and prognostic significance based on Duke Treadmill Score and imaging findings.',
      explanation: 'Cardiac stress testing integrates hemodynamic assessment, electrophysiologic monitoring, and optional imaging to evaluate coronary artery disease, risk stratify patients, and guide therapeutic decision-making. The choice of stress modality and imaging technique depends on the clinical question, patient characteristics, baseline ECG interpretability, and institutional expertise.\n\nExercise is the preferred stressor when patients can achieve adequate workload because it provides additional prognostic data including functional capacity, chronotropic response, heart rate recovery, and blood pressure response. Functional capacity measured in METs is one of the strongest predictors of all-cause mortality. Patients achieving greater than 10 METs have an excellent prognosis regardless of other findings. The Duke Treadmill Score (DTS) integrates exercise duration, maximum ST-segment deviation, and angina index: DTS = exercise time (minutes) - (5 x maximum ST deviation in mm) - (4 x angina index, where 0 = none, 1 = non-limiting, 2 = exercise-limiting). Scores classify patients as low risk (greater than or equal to +5), moderate risk (-10 to +4), or high risk (less than -10).\n\nHeart rate recovery, defined as the decrease in heart rate from peak exercise to 1 minute into recovery, is an important prognostic marker. A decrease of less than 12 beats per minute in the first minute of active recovery (or less than 18 bpm with passive recovery) is associated with increased mortality. Chronotropic incompetence, the inability to achieve 80% of heart rate reserve, is similarly prognostically significant.\n\nNuclear myocardial perfusion imaging (MPI) uses single-photon emission computed tomography (SPECT) or positron emission tomography (PET) to assess relative myocardial blood flow. The 17-segment model divides the left ventricle into standardized regions, each assigned to a coronary territory. Perfusion defects are characterized as fixed (present at both stress and rest, suggesting scar or infarction) or reversible (present at stress but resolving at rest, indicating ischemia). The summed stress score (SSS), summed rest score (SRS), and summed difference score (SDS) quantify the extent and severity of perfusion abnormalities. An SSS greater than 13 or SDS greater than 10 identifies patients at high risk who benefit from revascularization.\n\nStress echocardiography evaluates regional wall motion using a 16- or 17-segment model. Each segment is graded as normal (1), hypokinetic (2), akinetic (3), or dyskinetic (4). New or worsening wall motion abnormalities with stress indicate inducible ischemia. The wall motion score index (WMSI) is calculated by dividing the sum of individual segment scores by the number of visualized segments. Stress echo has the advantage of providing concurrent assessment of valvular function, left ventricular hypertrophy, and pericardial disease without radiation exposure.\n\nPharmacologic agent selection depends on the imaging modality: vasodilators (regadenoson, adenosine, dipyridamole) are used with nuclear imaging because they create differential flow, while dobutamine is preferred with echocardiography because it produces true wall motion changes through increased contractility and heart rate. Regadenoson has largely replaced adenosine and dipyridamole due to its selective A2A receptor agonism, fixed-dose bolus administration, and more favorable side effect profile. Dobutamine is administered in incremental doses (5, 10, 20, 30, 40 mcg/kg/min) at 3-minute intervals with atropine added if target heart rate is not achieved.',
      keyTerms: [
        { term: 'Duke Treadmill Score', definition: 'A composite prognostic score integrating exercise duration, ST-segment deviation, and angina to classify patients into low, moderate, or high cardiovascular risk categories' },
        { term: 'Heart rate recovery', definition: 'The decline in heart rate during the first minute after peak exercise; an abnormal response (less than 12 bpm decline) is an independent predictor of mortality' },
        { term: 'SPECT', definition: 'Single-photon emission computed tomography; a nuclear imaging technique that creates 3D images of myocardial perfusion using gamma-emitting radiotracers' },
        { term: 'Reversible perfusion defect', definition: 'A region of decreased radiotracer uptake during stress that normalizes at rest, indicating viable but ischemic myocardium' },
        { term: 'Wall motion score index', definition: 'A semiquantitative echocardiographic measure of regional ventricular function calculated by dividing the sum of wall motion scores by the number of segments analyzed' },
        { term: 'Regadenoson', definition: 'A selective adenosine A2A receptor agonist used as a pharmacologic vasodilator stress agent, administered as a single fixed-dose IV bolus' }
      ],
      clinicalNotes: 'The baseline ECG must be interpretable for exercise ECG testing to be diagnostic. Conditions rendering the ECG uninterpretable include left bundle branch block, ventricular paced rhythm, Wolff-Parkinson-White pattern, left ventricular hypertrophy with repolarization abnormalities, digitalis use, and greater than 1 mm baseline ST depression. In these patients, stress imaging (nuclear or echo) is mandatory. For patients with LBBB, vasodilator nuclear stress is preferred over exercise or dobutamine to avoid false-positive septal perfusion defects.'
    },
    4: {
      level: 4,
      summary: 'Advanced stress testing integrates PET quantitative perfusion, coronary flow reserve assessment, stress CMR, and computational techniques to evaluate microvascular disease, multi-vessel ischemic burden, and guide revascularization decisions in complex patients.',
      explanation: 'Advanced cardiac stress testing extends beyond conventional exercise ECG and standard SPECT imaging to incorporate quantitative perfusion assessment, hybrid imaging modalities, and novel physiologic parameters that improve diagnostic accuracy and prognostic stratification in complex clinical scenarios.\n\nPET myocardial perfusion imaging represents the gold standard for non-invasive quantitative myocardial blood flow (MBF) assessment. Using rubidium-82 or nitrogen-13 ammonia tracers with dynamic acquisition protocols, PET can measure absolute MBF in mL/g/min and calculate coronary flow reserve (CFR) as the ratio of hyperemic to resting MBF. Normal CFR is greater than 2.0, with values below 1.5 indicating significant flow impairment. Quantitative PET overcomes the limitation of relative perfusion imaging in balanced three-vessel disease, where proportionally reduced flow in all territories may appear falsely normal on SPECT. CFR integrates both epicardial and microvascular coronary function and has been shown to independently predict cardiac death with a hazard ratio of 3.1 for CFR less than 1.5.\n\nStress cardiac magnetic resonance (CMR) imaging provides comprehensive cardiac assessment without ionizing radiation. Adenosine or regadenoson stress CMR perfusion using gadolinium-based contrast agents achieves sensitivity of 89% and specificity of 87% for detecting significant CAD. First-pass perfusion imaging identifies subendocardial ischemia with superior spatial resolution compared to SPECT. Late gadolinium enhancement (LGE) concurrent with stress perfusion provides simultaneous viability and ischemia assessment. Stress CMR feature tracking allows quantification of myocardial strain during stress, identifying subclinical dysfunction before overt wall motion abnormalities develop.\n\nCoronary computed tomography angiography (CCTA) combined with CT-derived fractional flow reserve (CT-FFR) represents an emerging paradigm for anatomic-physiologic assessment. Computational fluid dynamics applied to standard CCTA data can estimate the hemodynamic significance of coronary stenoses without additional testing. The PLATFORM trial demonstrated that a CCTA/CT-FFR strategy safely reduced the need for invasive catheterization by 61% compared to usual care.\n\nAdvanced exercise parameters include oxygen consumption kinetics from cardiopulmonary exercise testing (CPET), which integrates cardiac, pulmonary, and peripheral determinants of exercise capacity. Peak VO2 less than 14 mL/kg/min or ventilatory efficiency (VE/VCO2 slope) greater than 36 carries prognostic significance in heart failure populations and guides transplant listing decisions. Exercise oscillatory ventilation (EOV) and the oxygen uptake efficiency slope (OUES) provide additional risk stratification.\n\nIn patients with intermediate-risk findings on initial stress testing, fractional flow reserve (FFR) during invasive angiography remains the reference standard for assessing the hemodynamic significance of epicardial coronary stenoses. FFR less than 0.80 identifies lesions that benefit from revascularization, as demonstrated in the FAME and FAME 2 trials. Instantaneous wave-free ratio (iFR) provides a resting index that correlates with FFR and avoids the need for adenosine administration during catheterization.',
      keyTerms: [
        { term: 'Coronary flow reserve (CFR)', definition: 'The ratio of maximal hyperemic myocardial blood flow to resting blood flow, quantified by PET; normal values exceed 2.0 and reduced CFR indicates epicardial or microvascular dysfunction' },
        { term: 'PET myocardial perfusion', definition: 'Positron emission tomography using rubidium-82 or nitrogen-13 ammonia for quantitative assessment of absolute myocardial blood flow and coronary flow reserve' },
        { term: 'Stress CMR', definition: 'Cardiac magnetic resonance imaging performed during vasodilator stress with gadolinium contrast to evaluate myocardial perfusion, wall motion, and viability without radiation' },
        { term: 'CT-FFR', definition: 'Computed tomography-derived fractional flow reserve using computational fluid dynamics applied to coronary CTA data to estimate the hemodynamic significance of stenoses' },
        { term: 'Cardiopulmonary exercise testing (CPET)', definition: 'An integrated assessment of cardiac, pulmonary, and metabolic function using simultaneous gas exchange analysis during graded exercise' },
        { term: 'Late gadolinium enhancement', definition: 'An MRI technique that identifies regions of myocardial fibrosis or scar by delayed accumulation of gadolinium contrast agent in damaged tissue' }
      ],
      clinicalNotes: 'PET MPI should be strongly considered when SPECT results are equivocal, in obese patients (BMI greater than 35) where attenuation artifacts degrade SPECT quality, and when multi-vessel disease is suspected. Stress CMR is contraindicated in patients with non-MRI-conditional devices, severe claustrophobia, and eGFR less than 30 due to nephrogenic systemic fibrosis risk with gadolinium. Regadenoson should be used with caution in patients with reactive airway disease; aminophylline should be readily available as a reversal agent.'
    },
    5: {
      level: 5,
      summary: 'Expert-level stress testing involves machine learning-enhanced interpretation, multi-modality fusion imaging, novel PET tracers for metabolic and molecular imaging, patient-specific computational modeling, and individualized risk assessment integrating genomic and biomarker data with functional testing results.',
      explanation: 'Expert-level cardiac stress testing encompasses emerging technologies, advanced quantitative techniques, and integrative approaches that push the boundaries of non-invasive cardiac assessment, often requiring specialized equipment, radiopharmaceuticals, and computational expertise available primarily at academic centers.\n\nMachine learning and artificial intelligence are transforming stress test interpretation. Deep learning algorithms applied to exercise ECG data can detect obstructive CAD with area under the curve (AUC) of 0.90, exceeding conventional ST-segment analysis (AUC 0.68). AI-enhanced nuclear imaging incorporates motion correction, attenuation correction optimization, and automated segmentation to reduce artifacts and improve diagnostic accuracy. Neural network-based analysis of stress echo can quantify subtle wall motion abnormalities below the threshold of visual detection, potentially identifying subclinical ischemia. The integration of clinical variables, hemodynamic response data, ECG features, and imaging findings through ensemble ML models creates comprehensive risk scores that outperform any individual parameter.\n\nNovel PET tracers enable molecular and metabolic imaging beyond perfusion assessment. Fluorine-18 fluorodeoxyglucose (F-18 FDG) PET combined with perfusion imaging is the gold standard for myocardial viability assessment, identifying hibernating myocardium with perfusion-metabolism mismatch patterns. F-18 sodium fluoride (NaF) PET identifies active coronary microcalcification and plaque vulnerability, potentially identifying high-risk lesions before they cause clinical events. Carbon-11 hydroxyephedrine and iodine-123 metaiodobenzylguanidine (I-123 MIBG) enable sympathetic innervation imaging, which has prognostic value in heart failure and arrhythmic risk stratification.\n\nAdvanced computational modeling uses patient-specific anatomic data from CCTA combined with computational fluid dynamics to simulate coronary hemodynamics under varying physiologic conditions. Virtual stress testing can model the impact of different revascularization strategies before intervention, enabling optimized treatment planning. Finite element modeling of myocardial mechanics can predict regions of stress concentration and ischemic vulnerability based on patient-specific geometry and tissue properties.\n\nMulti-parametric stress assessment integrating simultaneous PET/MR imaging combines the quantitative perfusion capabilities of PET with the tissue characterization strengths of MR in a single examination. This hybrid approach can simultaneously assess perfusion, metabolism, fibrosis, edema, and mechanical function, providing comprehensive phenotyping of ischemic heart disease. T1 and T2 mapping during stress MR can detect diffuse myocardial fibrosis and edema associated with microvascular dysfunction even in the absence of focal perfusion defects.\n\nPharmacogenomic considerations are increasingly recognized in stress testing. Genetic polymorphisms in adenosine receptors (ADORA2A) affect vasodilator stress response, potentially explaining variable diagnostic accuracy across populations. CYP2D6 metabolizer status influences dobutamine pharmacokinetics and stress response. Integration of polygenic risk scores for coronary artery disease with stress testing results may improve post-test probability calculations and guide downstream management more precisely than imaging alone.\n\nPrognosis-guided testing strategies use pre-test probability estimation incorporating the PROMISE or SCOT-HEART trial frameworks to select the optimal initial testing strategy. In populations with high pre-test probability, direct catheterization may be more efficient, while very low-risk patients may not require any testing. The concept of the diagnostic-therapeutic yield evaluates not just diagnostic accuracy but whether the test result changes management and improves outcomes, challenging the paradigm of routine stress testing in asymptomatic populations.',
      keyTerms: [
        { term: 'Machine learning-enhanced interpretation', definition: 'Application of deep learning algorithms to ECG, imaging, and clinical data to improve diagnostic accuracy and risk prediction beyond conventional analysis methods' },
        { term: 'F-18 NaF PET', definition: 'Fluorine-18 sodium fluoride PET imaging that identifies active microcalcification in coronary plaques, serving as a marker of plaque vulnerability and instability' },
        { term: 'PET/MR hybrid imaging', definition: 'Simultaneous positron emission tomography and magnetic resonance imaging providing combined quantitative perfusion, metabolic, and tissue characterization data' },
        { term: 'Hibernating myocardium', definition: 'Viable but chronically underperfused heart muscle with reduced contractile function that can recover after revascularization, identified by perfusion-metabolism mismatch on FDG-PET' },
        { term: 'Pharmacogenomics in stress testing', definition: 'The influence of genetic polymorphisms on individual responses to pharmacologic stress agents, affecting test sensitivity and side effect profiles' },
        { term: 'Computational fluid dynamics', definition: 'Mathematical simulation of blood flow through patient-specific coronary anatomy to predict hemodynamic significance of lesions without invasive measurement' }
      ],
      clinicalNotes: 'Emerging appropriate use criteria recommend incorporating pre-test probability assessment before ordering stress tests to optimize diagnostic yield. The 2022 ACC/AHA chest pain guidelines emphasize that testing should be reserved for patients in whom results will change management. For suspected microvascular disease (particularly in women), quantitative PET perfusion with CFR measurement is the most sensitive non-invasive approach. Always consider the radiation dose-benefit ratio: stress echo and stress CMR avoid ionizing radiation, SPECT delivers 8-12 mSv, PET delivers 3-5 mSv, and CCTA delivers 2-5 mSv with modern scanners.'
    }
  },
  media: [],
  citations: [
    { id: 'stress-c1', source: 'Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 Guideline Update for Exercise Testing. Circulation. 2002;106(14):1883-1892.', url: 'https://doi.org/10.1161/01.CIR.0000034670.06526.15' },
    { id: 'stress-c2', source: 'Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes. Eur Heart J. 2020;41(3):407-477.', url: 'https://doi.org/10.1093/eurheartj/ehz425' },
    { id: 'stress-c3', source: 'Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain. Circulation. 2021;144(22):e588-e637.', url: 'https://doi.org/10.1161/CIR.0000000000001029' }
  ],
  crossReferences: [
    { contentId: 'echo', relationship: 'related', description: 'Stress echocardiography as an imaging adjunct to exercise stress testing' },
    { contentId: 'cardiaccath', relationship: 'related', description: 'Cardiac catheterization as follow-up to abnormal stress test findings' },
    { contentId: 'pci', relationship: 'related', description: 'Percutaneous coronary intervention for ischemia identified on stress testing' }
  ],
  tags: {
    defined: ['cardiac-testing', 'stress-test', 'exercise-testing', 'nuclear-imaging', 'ischemia-evaluation', 'coronary-artery-disease', 'non-invasive-testing'],
    generated: ['bruce-protocol', 'pharmacologic-stress', 'SPECT', 'PET', 'stress-echo', 'duke-treadmill-score']
  },
  createdAt: '2025-01-25',
  updatedAt: '2025-01-25',
  version: 2,
  status: 'published'
};
